scholarly journals Studies on enzyme-linked immunosorbent assay (ELISA) for detection of antibodies in cattle infected with bovine leukemia virus.

1983 ◽  
Vol 45 (3) ◽  
pp. 347-353 ◽  
Author(s):  
Osamu KAJIKAWA ◽  
Hiroyuki KOYAMA ◽  
Takushi SASAKI ◽  
Takashi YOSHIKAWA ◽  
Hiroshi SAITO
2005 ◽  
Vol 17 (5) ◽  
pp. 451-457 ◽  
Author(s):  
Gustavo E. Monti ◽  
Klaas Frankena ◽  
Bas Engel ◽  
Willem Buist ◽  
Héctor D. Tarabla ◽  
...  

The objective of this study was to validate a new blocking enzyme-linked immunosorbent assay (ELISA) (designated M108 for milk and S108 for serum samples) for detecting bovine leukemia virus (BLV) infection in dairy cattle. Milk, serum, and ethylenediaminetetraacetic acid–blood samples were collected from 524 adult Holstein cows originating from 6 dairy herds in Central Argentina. The M108 and S108 were compared with agar gel immunodiffusion (AGID), polymerase chain reaction and a commercial ELISA. Because there is currently no reference test capable of serving as a gold standard, the test sensitivity (SE) and specificity (SP) were evaluated by the use of a latent class model. Statistical inference was performed by classical maximum likelihood and by Bayesian techniques. The maximum-likelihood analysis was performed assuming conditional independence of tests, whereas the Bayesian approach allowed for conditional dependence. No clear conclusion could be drawn about conditional dependence of tests. Results with maximum likelihood (under conditional independence) and posterior Bayes (under conditional dependence) were practically the same. Conservative estimates of SE and SP (with 95% confidence intervals) for M108 were 98.6 (96.7; 99.6) and 96.7 (92.9; 98.8) and for S108 99.5 (98.2; 99.9) and 95.4 (90.9; 98.1), respectively. The ELISA 108 using either milk or serum to detect BLV-infected animals had comparable SE and SP with the official AGID and a commercial ELISA test, which are currently the most widely accepted tests for the serological diagnosis of BLV infection. Therefore, ELISA 108 can be used as an alternative test in monitoring and control programs.


2004 ◽  
Vol 11 (1) ◽  
pp. 147-151 ◽  
Author(s):  
Antonio De Giuseppe ◽  
Francesco Feliziani ◽  
Domenico Rutili ◽  
Gian Mario De Mia

ABSTRACT The gene encoding the major envelope glycoprotein (gp51) with its signal sequence, represented by an additional NH2-terminal 33-residue amino acid sequence of bovine leukemia virus (BLV), was inserted into a baculovirus transfer vector. A recombinant virus expressing a secreted gp51 protein in insect cells was isolated. The recombinant gp51 expressed was characterized by using an anti-BLV monoclonal antibody by both Western blotting analysis and enzyme-linked immunosorbent assay (ELISA). The secreted gp51 was used as an antigen, and an ELISA with recombinant gp51 (rgp51) was developed for the detection of BLV antibodies. This new procedure was compared with a previous ELISA method for the detection of BLV antibodies and an agar gel immunodiffusion test performed with an unpurified BLV antigen preparation. The comparative testing of field samples showed that the ELISA with rgp51 is more specific and also suitable for the testing of pooled sera.


2019 ◽  
Vol 12 (3) ◽  
pp. 382-388
Author(s):  
Ekaterina Sergeevna Krasnikova ◽  
Fayssal Bouchemla ◽  
Alexander Vladimirovich Krasnikov ◽  
Roman Vladimirovich Radionov ◽  
Anastasia Sergeevna Belyakova

Aim: This study aimed to elucidate the ability of the bovine leukemia virus (BLV) to integrate into cells of heterologous organisms, in particular, Wistar rats, and examine the manifestations of the pathological process that could be seen in them. Materials and Methods: Wistar rats - were divided into three groups. The first group (I) was fed milk of intact cows, the second (II) - milk of BLV-infected cows, and the third (III) - milk of cows, clinically BLV sick. Rats of all groups were divided into two subgroups: In the subgroup "a", there were adult rats, and in the subgroup "b", their offspring were included. At 3, 6, 9, and 12 months from the start of the experiment, the animals' blood of each group was examined by polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay for the presence of BLV provirus and specific anti-leukemia antibodies. A general and biochemical blood test was performed; pathological changes in the internal organs were recorded. Results: Using the PCR, the BLV infection was established in all experimental rats, whose immune response was expressed in varying degrees. At the initial stage of the infection, offspring rats were born healthy. The rats of the control groups Ia and Ib were intact to the BLV throughout the experiment. The biochemical blood tests have shown several signs of intoxication, endocrine disorders, and development of malignant processes in the experimental animals. There are also signs of liver, kidney, and myocardial damages, regardless of whether milk is infected or the cows are clinically leukemic. By the time, the experimental rats developed persistent thrombocytosis with an increase in the average volume of the blood platelets, which may be evidence of the leukemia infection by the megakaryocytic type. The most pronounced character of the change was in the offspring generation. Conclusion: Wistar rats can be considered as a suitable laboratory model to study the BLV pathogenesis. Rats are not BLV natural host, however, they developed the pathognomonic BLV infection symptoms when they were fed infected and leukemic cow's milk.


2017 ◽  
Vol 29 (5) ◽  
pp. 704-706 ◽  
Author(s):  
Fernando V. Bauermann ◽  
Julia F. Ridpath ◽  
David A. Dargatz

Infection with bovine leukemia virus (BLV) results in economic loss because of reduced productivity, especially reduced milk production, and early culling. In the United States, studies in 1996, 1999, and 2007 showed BLV infection to be widespread, especially in dairy herds. We updated information herein on BLV seroprevalence in the United States, using samples submitted for testing and found negative for antibodies for Brucella by the Kentucky Eastern Regional Federal Brucellosis Laboratory. From October 2014 through August 2015, 2,000 samples from all regions of the contiguous United States were selected and tested for BLV antibodies by enzyme-linked immunosorbent assay. The overall percentage of samples positive for BLV antibody was 38.6%. Based on the animal’s origin, the percent positive by region ranged from 32.5% (Mountain West region) to 54.3% (Northeast region; p < 0.05). The positive rate for slaughter plants that processed mainly dairy animals (dairy plants; 47.6%) was higher than the positive rate at slaughter plants that processed mainly beef animals (beef plants; 33.6%; p < 0.05). The results suggest that BLV infection remains widespread in all regions of the United States and that rates may differ between beef and dairy cattle.


Sign in / Sign up

Export Citation Format

Share Document